| MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ... Nature 471 (7338), 377-381, 2011 | 722 | 2011 |
| High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma A Van den Berg, BJ Kroesen, K Kooistra, D de Jong, J Briggs, T Blokzijl, ... Genes, Chromosomes and Cancer 37 (1), 20-28, 2003 | 347 | 2003 |
| A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) V Enciso-Mora, P Broderick, Y Ma, RF Jarrett, H Hjalgrim, K Hemminki, ... Nature genetics 42 (12), 1126-1130, 2010 | 243 | 2010 |
| HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma M Niens, RF Jarrett, B Hepkema, IM Nolte, A Diepstra, M Platteel, ... Blood, The Journal of the American Society of Hematology 110 (9), 3310-3315, 2007 | 211 | 2007 |
| Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma A Diepstra, M Niens, E Vellenga, GW Van Imhoff, IM Nolte, M Schaapveld, ... The Lancet 365 (9478), 2216-2224, 2005 | 208 | 2005 |
| Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues E Maggio, A van den Berg, A Diepstra, J Kluiver, L Visser, S Poppema Annals of oncology 13, 52-56, 2002 | 200 | 2002 |
| Genome-wide association study of classical Hodgkin lymphoma and Epstein–Barr virus status–defined subgroups KY Urayama, RF Jarrett, H Hjalgrim, A Diepstra, Y Kamatani, A Chabrier, ... Journal of the National Cancer Institute 104 (3), 240-253, 2012 | 194 | 2012 |
| HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma A Diepstra, GW van Imhoff, HE Karim-Kos, A van den Berg, ... Journal of clinical oncology 25 (21), 3101-3108, 2007 | 168 | 2007 |
| Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma C Steidl, A Diepstra, T Lee, FC Chan, P Farinha, K Tan, A Telenius, ... Blood, The Journal of the American Society of Hematology 120 (17), 3530-3540, 2012 | 161 | 2012 |
| Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes Y Ma, L Visser, H Roelofsen, M de Vries, A Diepstra, G van Imhoff, ... Blood, The Journal of the American Society of Hematology 111 (4), 2339-2346, 2008 | 157 | 2008 |
| The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component Y Liu, A Sattarzadeh, A Diepstra, L Visser, A van den Berg Seminars in cancer biology 24, 15-22, 2014 | 146 | 2014 |
| Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22 M Niens, L Visser, IM Nolte, G Van Der Steege, A Diepstra, P Cordano, ... British journal of haematology 140 (5), 527-536, 2008 | 142 | 2008 |
| miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes LP Tan, M Wang, JL Robertus, RN Schakel, JH Gibcus, A Diepstra, ... Laboratory investigation 89 (6), 708-716, 2009 | 140 | 2009 |
| Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy GP Basadonna, L Auersvald, CQ Khuong, XX Zheng, N Kashio, D Zekzer, ... Proceedings of the National Academy of Sciences 95 (7), 3821-3826, 1998 | 121 | 1998 |
| Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients A Diepstra, GW van Imhoff, M Schaapveld, H Karim-Kos, A van den Berg, ... Journal of clinical oncology 27 (23), 3815-3821, 2009 | 120 | 2009 |
| HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy? M Nijland, RN Veenstra, L Visser, C Xu, K Kushekhar, GW van Imhoff, ... Oncoimmunology 6 (4), e1295202, 2017 | 114 | 2017 |
| Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma A van den Berg, E Maggio, R Rust, K Kooistra, A Diepstra, S Poppema Blood, The Journal of the American Society of Hematology 100 (4), 1425-1429, 2002 | 113 | 2002 |
| Prospective isolation and characterization of genetically and functionally distinct AML subclones B de Boer, J Prick, MG Pruis, P Keane, MR Imperato, J Jaques, ... Cancer cell 34 (4), 674-689. e8, 2018 | 110 | 2018 |
| Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity BB Beck, FJ van Spronsen, A Diepstra, RMF Berger, M Kömhoff Pediatric nephrology 32, 733-741, 2017 | 109 | 2017 |
| HLA‐G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma A Diepstra, S Poppema, M Boot, L Visser, IM Nolte, M Niens, ... Tissue antigens 71 (3), 219-226, 2008 | 109 | 2008 |